Half-yearly report on Inventiva's liquidity contract with Kepler Cheuvreux

Biopharmaceutical company Inventiva has revealed the half-yearly balance sheet of its liquidity contract with Kepler Cheuvreux as of December 31, 2024. In total, the liquidity account showed 349,630.55 euros in cash and 113,452 Inventiva shares. As for transactions, 1,281 purchase transactions were carried out for 215,444 shares traded, representing 477,452.69 euros. Sales totaled 1,366 transactions for 231,651 shares, equivalent to 538,913.35 euros.

Compared to the previous half-year balance sheet of June 30, 2024, cash had already reached 285,764.46 euros, with 129,659 shares held. During this period, the volume traded for purchase amounted to 322,578 shares for 1,074,534.26 euros, while for sales, 276,147 shares had been traded for 938,985.90 euros.